Signal transduction pathways in acute myetoid leukemia
Promotie: mw. L. Han, 13.15 uur, Academiegebouw, Broerstraat 5, Groningen
Proefschrift: Signal transduction pathways in acute myetoid leukemia
Promotor(s): prof.dr. E. Vellenga
Faculteit: Medische Wetenschappen
Contact: via de persvoorlichters van het UMCG, tel. 050-361 2200, e-mail: voorlichting bvl.umcg.nl
Signal transduction pathways in acute myetoid leukemia
Acute myeloid leukemia (AML) is characterized by the uncontrolled accumulation of abnormal white blood cells in the bone marrow that replace normal blood cells, including red blood cells, platelets and normal white blood cells. The symptoms include fatigue, shortness of breath, bleeding, and high risk of infection. Emerging studies consider that leukemic stem cells (LSCs) initiate and maintain AML, and their quiescent state contributes to resistance of chemotherapy. A number of abnormal signaling pathways have been identified in AML LSCs. A novel inhibitor dasatinib was demonstrated to be a potential inhibitor in a subgroup of AML.
Last modified: | 13 March 2020 01.16 a.m. |
More news
-
06 June 2025
India-Netherlands Hydrogen Valley Fellowship Programme announced
To coincide with World Environment Day, 5 June 2025, the Indian Department of Science and Technology and the University of Groningen yesterday announced a Hydrogen Valley Fellowship Programme Partnership, allowing talented Indian scholars working on...
-
24 March 2025
UG 28th in World's Most International Universities 2025 rankings
The University of Groningen has been ranked 28th in the World's Most International Universities 2025 by Times Higher Education. With this, the UG leaves behind institutions such as MIT and Harvard. The 28th place marks an increase of five places: in...
-
05 March 2025
Women in Science
The UG celebrates International Women’s Day with a special photo series: Women in Science.